Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-24 - Ranibizumab
openTechniker Krankenkasse · 992-80116-93
Value
unstated
Published
30 Sept 2025
Deadline
31 Oct 2026, 22:58 GMT · 7d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600
Description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ranibizumab im Rahmen eines Open-House-Verfahrens.
Key facts
- Procedure
- open
- Contact
- DZEM@tk.de
- Contract period
- 1 Nov 2025 → 31 Oct 2026
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 637367-2025
- First seen
- 22 Aug 2026
- Last updated
- 22 Aug 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/007c0b3c-a6f4-49fe-b85c-55eec258876fThe source notice is authoritative — verify deadlines and documents there before bidding.